Medical specialists from France tagged as investigators in clinical trials studying Acute Lymphoblastic Leukemia

Total 76 results

Andre Baruchel, MD
Seen in:
- Paris, University Hospital Robert Debre
Trials:
- NCT04984356 (Principal Investigator)
Conditions:
- Lymphoblastic Lymphoma;
- T-cell Acute Lymphoblastic Leukemia
Anne Jourdain, MD
Seen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:
- NCT05792007 (Sub-Investigator)
Conditions:
- Acute Lymphoid Leukemia;
- Acute Myeloid Leukemia in Children
Anne Sirvent, MD PhD
Seen in:
- Montpellier, Hôpital Arnaud de Villeneuve
Trials:
- NCT01949129 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukaemia
Arnaud Petit, M.D.
Seen in:
- Paris, CHU Paris Armand Trousseau
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Aurélie CABANNES-HAMY
Seen in:
- Paris, CABANNES-HAMY Aurélie
Trials:
- NCT03751072 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukemia, in Relapse;
- Acute Lymphoblastic Leukemia With Failed Remission
Benedicte Bruno, MD PhD
Seen in:
- Lille, CHRU Lille, Service d'Hématologie Pédiatrique
Trials:
- NCT01949129 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukaemia
Camille Leglise, M.D.
Seen in:
- Amiens Cedex 1, CHU Amiens Groupe Hospitalier Sud
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Carine HALFON-DOMENECH, M.D, PhD
Seen in:
- Lyon Cedex 08, CHU de Lyon HCL - GH Est-Institut d'hématologie et d'oncologie pédiatrique IHOP
- Lyon, Institut D'Hematologie Et D'Oncologie Pediatrique
Trials:
- NCT03278145 (Principal Investigator)
- NCT04307576 (Principal Investigator)
Conditions:
Caroline Thomas, M.D.
Seen in:
- Nantes Cedex 01, CHU Nantes-Hôpital enfant-adolescent
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Catherine Devoldere, M.D.
Seen in:
- Amiens Cedex 1, CHU Amiens Groupe Hospitalier Sud
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Catherine Paillard, M.D.
Seen in:
- Strasbourg Cedex, CHU Strasbourg -Hôpital de Hautepierre
- Strasbourg, CHU Strasbourg, Service d'hématologie et d'oncologie pédiatrique
Trials:
- NCT04307576 (Principal Investigator)
- NCT01949129 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic;
- Acute Lymphoblastic Leukaemia
Cécile Pochon, M.D.
Seen in:
- Nancy, CHU Nancy - Hôpital d'Enfants
- Vandoeuvre-les-nancy cedex, CHU de Nancy - Hôpital de Brabois Enfant
Trials:
- NCT04307576 (Principal Investigator)
- NCT01949129 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic;
- Acute Lymphoblastic Leukaemia
Charlotte Jubert, MD PhD
Seen in:
- Bordeaux, CHU Bordeaux
Trials:
- NCT01949129 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukaemia
Christophe Piguet, M.D.
Seen in:
- Limoges, Hôpital de la mère et de l'enfant
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Claire Desplantes, M.D.
Seen in:
- Dijon, CHU Dijon Hôpital François Mitterrand
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Claire Pluchart, M.D.
Seen in:
- Reims, CHU Reims-American Hospital
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Corine Armari Alla
Seen in:
- Grenoble Cedex 9, CHU de Grenoble site Nord - Hôpital Albert Michallon
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Damien Bodet, M.D.
Seen in:
- Caen Cedex 9, Centre Hospitalier Universitaire Caen
Trials:
- NCT04307576 (Principal Investigator)
Conditions:
- Leukemia, Acute Lymphoblastic
Dominique Plantaz, MD PhD
Seen in:
- Grenoble, CHU Grenoble - Clinique Universitaire de Pédiatrie, Hôpital Couple Enfant
Trials:
- NCT01949129 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukaemia
Emmanuel Gyan, MD-PhD
Seen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:
- NCT05792007 (Sub-Investigator)
Conditions:
- Acute Lymphoid Leukemia;
- Acute Myeloid Leukemia in Children
Fanny Rialland, MD PhD
Seen in:
- Nantes, CHU Nantes, Service d'onco hémato pédiatrie
Trials:
- NCT01949129 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukaemia
Francoise Huguet
Seen in:
- Angers, CRLCC Centre Paul Papin
- Midi-pyrenees, Toulouse Cedex 09, Institut Universitaire du Cancer de Toulouse Oncopole
- Toulouse, University Hospital, Toulouse
Trials:
- NCT03589326 (Principal Investigator)
- NCT00188084 (Sub-Investigator)
- NCT05963061 (Sub-Investigator)
Conditions:
Frédéric Millot
Seen in:
- Poitiers Cedex 6, CHU Poitiers
- Poitiers, Chu Poitiers Chu La Miletrie
Trials:
- NCT04307576 (Principal Investigator)
- NCT05180825 (Principal Investigator)
Conditions:
Gerard Michel, MD PhD
Seen in:
- Marseille, Hopital la Timone Adulte
Trials:
- NCT01949129 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukaemia
Guillaume CARTRON, MD PHD
Seen in:
- Montpellier, CHU Montpellier
- Montpellier, Département d'hématologie clinique
Trials:
- NCT04703686 (Principal Investigator)
- NCT04290000 (Principal Investigator)
Conditions:
Jean-Hugues Dalle, MD PhD
Seen in:
- Paris, Hôpital Robert Debré
Trials:
- NCT01949129 (Principal Investigator)
Conditions:
- Acute Lymphoblastic Leukaemia

Clinical Trials on Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Completed

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

B-cell Adult Acute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell... and other conditions

United States
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult T Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Adult L1 Acute Lymphoblastic Leukemia | Adult L2 Acute Lymphoblastic...

United States
Autolus Limited

Completed

CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) (AMELIA)

Recurrent Childhood Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | B-cell Acute Lymphoblastic Leukemia | Refractory Childhood Acute Lymphoblastic Leukemia

United Kingdom
Children's Oncology Group
National Cancer Institute (NCI); ImmunoGen, Inc.

Withdrawn

A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent...
University of Birmingham
AstraZeneca; Cancer Research UK

Terminated

International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia (SeluDex)

Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Adult | Acute Lymphoblastic Leukemia Recurrent

United Kingdom, Denmark, Netherlands
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Recurrent Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Non-T, Non-B Childhood Acute Lymphoblastic Leukemia

United States
University College, London

Not yet recruiting

Determining the Mechanisms of Loss of CAR T Cell Persistence (CARPERS)

Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Adult | Acute Lymphoblastic Leukemia With Failed Remission | Acute Lymphoblastic Leukemia Not Having Achieved Remission
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Childhood Acute Lymphoblastic Leukemia in Remission | Graft Versus Host Disease | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia

United States, Canada, Australia
Medical College of Wisconsin
Children's Hospital and Health System Foundation, Wisconsin

Recruiting

CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL (CAR-20/19-T)

Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia Recurrent | Acute Lymphoblastic Leukemia With Failed Remission | Acute Lymphoblastic Leukemia Not Having Achieved Remission

United States
Therapeutic Advances in Childhood Leukemia Consortium
Enzon Pharmaceuticals, Inc.

Terminated

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Lymphoblastic Leukemia, Acute, Childhood | Leukemia, Lymphoblastic, Acute | Lymphoblastic Leukemia, Acute | Leukemia, Lymphoblastic, Acute, T Cell

United States, Australia

Medical specialists from France tagged as investigators in clinical trials studying Acute Lymphoblastic Leukemia

Clinical Trials on Acute Lymphoblastic Leukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations